Excimer laser platform shows excellent results in large series of patients
Click Here to Manage Email Alerts
BERLIN — A new excimer laser platform allows a safe and effective treatment of a wide range of refractive errors, according to a study carried out in Athens, Greece.
The study, which used the Schwind Amaris excimer laser with the ORK-CAM ablation profile, looked at a total of 160 eyes with myopia and myopic astigmatism and 15 hyperopic eyes treated since March 2008.
"Results were extremely good, with 90% of the eyes achieving 20/20 uncorrected vision with both techniques, although PRK-treated eyes required a slightly longer time to recover. None of the eyes lost BCVA lines. All eyes were between ±0.5 and ±1 D from target refraction, with just a slight tendency to overcorrection in higher myopia," George Charonis, MD, said at the European Society of Cataract and Refractive Surgeons meeting here.
Stability of results appears to be excellent at this point of the follow up.
The surgeons involved performed either PRK or LASIK, using the Carriazo Pendular microkeratome to create the LASIK flap.